- Filed
- Nov 4, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 27, 2025 | 268.11M sh |
| Shares Diluted | Q3 2025 · Oct 3, 2025 | 278.54M sh |
| Shares Diluted | Q3 2025 · Oct 3, 2025 | 283.7M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2024 | 291.48M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2024 | 296.99M sh |
| Stock Repurchased | Q3 2025 · Oct 3, 2025 | $689.89M |
| Stock Repurchased | Q3 2025 · Sep 27, 2024 | $461.62M |
| Capex | Q3 2025 · Oct 3, 2025 | $7.27M |
| Capex | Q3 2025 · Sep 27, 2024 | $24.46M |
| Operating Cash Flow | Q3 2025 · Oct 3, 2025 | $550.75M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2024 | $459.71M |
| Cash And Equivalents | Q3 2025 · Oct 3, 2025 | $376.3M |
| Cash And Equivalents | Q3 2025 · Jan 3, 2025 | $217.37M |
| Stockholders Equity | Q3 2025 · Oct 3, 2025 | $2.16B |
| Stockholders Equity | Q3 2025 · Jul 4, 2025 | $2.03B |
| Stockholders Equity | Q3 2025 · Jan 3, 2025 | $2.24B |
| Stockholders Equity | Q3 2025 · Sep 27, 2024 | $2.28B |
| Stockholders Equity | Q3 2025 · Jun 28, 2024 | $2.12B |
| Stockholders Equity | Q3 2025 · Dec 29, 2023 | $2.26B |
| Current Liabilities | Q3 2025 · Oct 3, 2025 | $373.78M |
| Current Liabilities | Q3 2025 · Jan 3, 2025 | $403.77M |
| Total Liabilities | Q3 2025 · Oct 3, 2025 | $662.85M |
| Total Liabilities | Q3 2025 · Jan 3, 2025 | $703.49M |
| Current Assets | Q3 2025 · Oct 3, 2025 | $1.4B |
| Current Assets | Q3 2025 · Jan 3, 2025 | $1.47B |
| Total Assets | Q3 2025 · Oct 3, 2025 | $2.82B |
| Total Assets | Q3 2025 · Jan 3, 2025 | $2.95B |
| Eps Diluted | Q3 2025 · Oct 3, 2025 | $0.69 |
| Eps Diluted | Q3 2025 · Oct 3, 2025 | $1.90 |
| Eps Diluted | Q3 2025 · Sep 27, 2024 | $0.40 |
| Eps Diluted | Q3 2025 · Sep 27, 2024 | $1.28 |
| Eps Basic | Q3 2025 · Oct 3, 2025 | $0.72 |
| Eps Basic | Q3 2025 · Oct 3, 2025 | $1.97 |
| Eps Basic | Q3 2025 · Sep 27, 2024 | $0.41 |
| Eps Basic | Q3 2025 · Sep 27, 2024 | $1.31 |
| Sga Expense | Q3 2025 · Oct 3, 2025 | $123.66M |
| Sga Expense | Q3 2025 · Oct 3, 2025 | $395.7M |
| Sga Expense | Q3 2025 · Sep 27, 2024 | $111.8M |
| Sga Expense | Q3 2025 · Sep 27, 2024 | $357.8M |
| Rd Expense | Q3 2025 · Oct 3, 2025 | $199.16M |
| Rd Expense | Q3 2025 · Oct 3, 2025 | $611.75M |
| Rd Expense | Q3 2025 · Sep 27, 2024 | $222.57M |
| Rd Expense | Q3 2025 · Sep 27, 2024 | $661.41M |
| Net Income | Q3 2025 · Oct 3, 2025 | $193.58M |
| Net Income | Q3 2025 · Oct 3, 2025 | $538.04M |
| Net Income | Q3 2025 · Sep 27, 2024 | $117.97M |
| Net Income | Q3 2025 · Sep 27, 2024 | $381.41M |
| Operating Income | Q3 2025 · Oct 3, 2025 | $236.54M |
| Operating Income | Q3 2025 · Oct 3, 2025 | $636.98M |
| Operating Income | Q3 2025 · Sep 27, 2024 | $136.08M |
| Operating Income | Q3 2025 · Sep 27, 2024 | $441.41M |
| Cost Of Revenue | Q3 2025 · Oct 3, 2025 | $18.57M |
| Cost Of Revenue | Q3 2025 · Oct 3, 2025 | $57.22M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2024 | $17.33M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2024 | $56.25M |
| Revenue | Q3 2025 · Oct 3, 2025 | $597.76M |
| Revenue | Q3 2025 · Oct 3, 2025 | $1.72B |
| Revenue | Q3 2025 · Sep 27, 2024 | $539.54M |
| Revenue | Q3 2025 · Sep 27, 2024 | $1.6B |